Lemborexant for better sleep in shift workers
Treatments studied
Part of Brain & nervous system clinical trials.
This study tests a sleep medication called lemborexant to see if it helps people who work rotating shifts sleep better and feel less sleepy during their shifts.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 20 and 60 years old.
- You work rotating shifts (changing day, evening, or night) and have for at least 3 months.
- You have trouble sleeping (less than 6 hours or not sleeping well) and feel sleepy during work.
- You are not currently taking certain medications that interact with the study drug (like strong CYP3A4 inducers or inhibitors).
- You do not have untreated or unstable mental health conditions, sleep apnea, restless legs, or other sleep disorders.
- You are not pregnant or breastfeeding and can limit caffeine and alcohol as needed.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new sleep medicine called lemborexant for people with epilepsy whose seizures happen during sleep and who also have trouble sleeping. The goal is to see if the medicine can help you sleep better without making your seizures worse.
This trial tests if lemborexant, a sleep medication, can help prevent confusion (delirium) after open-heart surgery. If you are having heart surgery through a chest incision, you may be able to join.
This trial tests whether a once-daily sleep medication, lemborexant, can help people with moderate obstructive sleep apnea who have a low arousal threshold (wake up easily from sleep). It aims to find the best one-month dosing schedule.
This study tests if lemborexant, a sleep medication, can help people with both a mental health condition and insomnia. You would take the medicine as prescribed and complete questionnaires over 2 months.
This trial tests whether a medication called Lemborexant can improve sleep problems and movement symptoms in people with Parkinson's disease. If you have trouble sleeping due to insomnia and have had Parkinson's for at least 2 years, this study may help.
This trial tests whether a medication that blocks brain chemicals involved in wakefulness can help reduce markers of nerve damage in people with insomnia. It is for adults aged 40–65 with chronic insomnia, and it aims to see if improving sleep may protect brain health.
Hear when a new Sleep trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.